41.85
前日終値:
$47.27
開ける:
$45.135
24時間の取引高:
3.76M
Relative Volume:
3.06
時価総額:
$2.25B
収益:
$238.11M
当期純損益:
$-31.45M
株価収益率:
-66.07
EPS:
-0.6334
ネットキャッシュフロー:
$7.66M
1週間 パフォーマンス:
-11.15%
1か月 パフォーマンス:
-13.21%
6か月 パフォーマンス:
+36.36%
1年 パフォーマンス:
+160.42%
Axogen Inc Stock (AXGN) Company Profile
Compare AXGN vs ABT, MDT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
AXGN
Axogen Inc
|
41.85 | 2.54B | 238.11M | -31.45M | 7.66M | -0.6334 |
|
ABT
Abbott Laboratories
|
103.36 | 182.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
91.62 | 117.54B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
270.01 | 105.63B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.10 | 65.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.77 | 49.67B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-19 | 開始されました | Wells Fargo | Overweight |
| 2025-12-01 | 開始されました | Mizuho | Outperform |
| 2025-03-17 | 開始されました | Lake Street | Buy |
| 2024-07-01 | 開始されました | Raymond James | Outperform |
| 2022-11-11 | 再開されました | Jefferies | Buy |
| 2022-05-09 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 開始されました | Guggenheim | Buy |
| 2020-06-16 | 再開されました | Cantor Fitzgerald | Overweight |
| 2020-05-07 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-08-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | 開始されました | Canaccord Genuity | Buy |
| 2018-03-02 | 繰り返されました | Lake Street | Buy |
| 2018-01-05 | 再開されました | Cantor Fitzgerald | Overweight |
| 2017-11-30 | 開始されました | Jefferies | Buy |
| 2017-11-21 | 繰り返されました | Lake Street | Buy |
| 2017-07-31 | 開始されました | Leerink Partners | Outperform |
| 2017-06-30 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-03-06 | 開始されました | ROTH Capital | Buy |
| 2016-11-22 | アップグレード | Lake Street | Hold → Buy |
| 2016-11-07 | 繰り返されました | Wedbush | Outperform |
| 2016-11-03 | ダウングレード | Lake Street | Buy → Hold |
| 2016-08-04 | 繰り返されました | Wedbush | Outperform |
| 2014-05-14 | 開始されました | Dawson James | Buy |
| 2013-10-31 | 繰り返されました | Ladenburg Thalmann | Buy |
すべてを表示
Axogen Inc (AXGN) 最新ニュース
Why Is Axogen Stock Tumbling Today?Axogen (NASDAQ:AXGN) - Benzinga
Axogen to buy BioCircuit Technologies for $200M - MedTech Dive
2 Medical-Device Stocks Lighting Up the Options Pits - Schaeffer's Investment Research
Axogen stock falls as $208.7M offering dilutes shareholders - Investing.com
Axogen Prices $208.7 Million Stock Offering to Fund BioCircuit Acquisition - citybiz
Axogen to Acquire BioCircuit Technologies in $200 Million Nerve Repair Deal - citybiz
Why is Axogen stock sliding today? By Investing.com - Investing.com Canada
Why is Axogen stock sliding today? - Investing.com
Axogen acquires BioCircuit Technologies for $200 million - grafa.com
Axogen Announces Pricing Of $208.7 Million Public Offering Of Common Stock - TradingView
AxoGen to Acquire BioCircuit, Expanding Nerve Repair Portfolio - TipRanks
Axogen prices $208.7 million stock offering at $42.50 per share - Investing.com
AXGN Looks 171.8% Overvalued on GF Value™ - GuruFocus
Form 8K Axogen Inc For: 10 September By Investing.com - Investing.com Canada
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock - The Manila Times
Axogen prices $208.7 million stock offering at $42.50 per share By Investing.com - Investing.com Canada
Axogen Prices $208.7 Million Public Offering of Common Stock to Help Fund BioCircuit Acquisition - Quiver Quantitative
AXGN: Acquisition of a pioneering sutureless nerve repair device is expected to drive growth and innovation - TradingView
Axogen to acquire BioCircuit for $200M, adds nerve repair device - Investing.com UK
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies - GlobeNewswire
Understanding the Setup: (AXGN) and Scalable Risk - Stock Traders Daily
Axogen Director Tyndall Joseph A. Disposes of 3,500 Shares at $49.70 Each - Kalkine Media
Axogen (AXGN) Director Joseph Tyndall Sells 3,500 Shares - GuruFocus
Axogen Inc (AXGN) Shares Fall 3.2% -- What GF Score of 64 Tells Investors - GuruFocus
Axogen (NASDAQ: AXGN) director plans $174K stock sale - stocktitan.net
Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference - Yahoo Finance
Axogen stock hits 52-week high at 51.13 USD By Investing.com - Investing.com South Africa
Axogen Inc (AXGN) Stock Up 3.3% but GF Value Says Overvalued -- GF Score: 64/100 - GuruFocus
Truist initiates AxoGen stock with buy rating on growth potential By Investing.com - Investing.com Canada
Truist Financial Initiates AxoGen(AXGN.US) With Buy Rating, Announces Target Price $60 - Moomoo
Axogen (AXGN) Close: Ends Lower by 2.32% at $49.23 in the Latest Reading; Immediate View - vinanet.vn
AxoGen (AXGN) Tops Q2 Earnings and Revenue Estimates - Eastern Progress
Axogen (AXGN) Price: Adds 8.53% to Close at $50.40 in the Latest Session; Market Levels: Price Remains Between $47.88 Support and $52.92 Resistance on the DayMedian Line - siam.in
Axogen Inc (AXGN) Shares Surge 8.5% -- What GF Score of 66 Tells Investors - GuruFocus
Axogen Inc (NASDAQ: AXGN) Share Price, AXGN Stock News, AXGN Share Price & Updates - kalkine.ca
Price to sales ratio of Axogen, Inc. – BMV:AXGN - TradingView
31,800 Shares in AxoGen, Inc. $AXGN Bought by Edmond DE Rothschild Holding S.A. - MarketBeat
Price to sales ratio of Axogen, Inc. – BIVA:AXGN - TradingView
Taxes of Axogen, Inc. – BMV:AXGN - TradingView
ETFs Investing in Axogen, Inc. Stocks - TradingView
AXGN Stock Price and Chart — BIVA:AXGN - TradingView
Cash per share of Axogen, Inc. – BMV:AXGN - TradingView
Axogen, Inc. Cash Flow – BIVA:AXGN - TradingView
Axogen, Inc. Statistics – BMV:AXGN - TradingView
Lisanti Capital Growth LLC Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
Tocqueville Asset Management L.P. Takes $8.03 Million Position in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 52-Week HighHere's Why - MarketBeat
Axogen stock reaches 52-week high at 50.0 USD By Investing.com - Investing.com Canada
Axogen stock reaches 52-week high at 50.0 USD - Investing.com
Rice Hall James & Associates LLC Invests $3.41 Million in AxoGen, Inc. $AXGN - MarketBeat
689,833 Shares in AxoGen, Inc. $AXGN Bought by TimesSquare Capital Management LLC - MarketBeat
Axogen Inc (AXGN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):